Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GE Healthcare to acquire UK bioprocessing firm Puridify

GE Healthcare to acquire UK bioprocessing firm Puridify

14th December 2017

GE Healthcare has announced the acquisition of Puridify, a UK-based bioprocessing start-up developing technology to aid the production of new medicines.

Puridify was formed in 2013 as a spin-out from University College London, and is working on a nanofibre-based platform purification technology for biopharmaceutical production.

Its FibroSelect technology is designed to be complementary to the bead resins and chromatography membranes used in downstream bioprocessing, meaning it can deliver faster mass transfer, scalability and ease of use.

All 17 Puridify employees will join GE Healthcare Life Sciences' bioprocess division, with the team set to remain at their current location in Stevenage, which will serve as a small research hub.

Following the completion of the deal, GE Healthcare will invest further to bring Puridify's platform to commercialisation, while fully integrating the solution within its existing range of bioprocess purification products.

Jan Makela, general manager for GE Healthcare Life Sciences' bioprocess business, said: "Our goal is to introduce significant improvements to bioprocessing, and being part of GE helps us to maximise this opportunity. This deal gives full recognition to Puridify's development team and to the strong potential of the FibroSelect technology platform."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.